Cargando…

Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway

Detalles Bibliográficos
Autores principales: Saraswati, Sarita, Kumar, Shakti, Alhaider, Abdulqader A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753275/
https://www.ncbi.nlm.nih.gov/pubmed/36522753
http://dx.doi.org/10.1186/s12943-022-01700-y
_version_ 1784850929770561536
author Saraswati, Sarita
Kumar, Shakti
Alhaider, Abdulqader A.
author_facet Saraswati, Sarita
Kumar, Shakti
Alhaider, Abdulqader A.
author_sort Saraswati, Sarita
collection PubMed
description
format Online
Article
Text
id pubmed-9753275
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97532752022-12-16 Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway Saraswati, Sarita Kumar, Shakti Alhaider, Abdulqader A. Mol Cancer Retraction Note BioMed Central 2022-12-15 /pmc/articles/PMC9753275/ /pubmed/36522753 http://dx.doi.org/10.1186/s12943-022-01700-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Saraswati, Sarita
Kumar, Shakti
Alhaider, Abdulqader A.
Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title_full Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title_fullStr Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title_full_unstemmed Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title_short Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
title_sort retraction note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated akt/mtor/p70s6k signaling pathway
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753275/
https://www.ncbi.nlm.nih.gov/pubmed/36522753
http://dx.doi.org/10.1186/s12943-022-01700-y
work_keys_str_mv AT saraswatisarita retractionnoteasantalolinhibitstheangiogenesisandgrowthofhumanprostatetumorgrowthbytargetingvascularendothelialgrowthfactorreceptor2mediatedaktmtorp70s6ksignalingpathway
AT kumarshakti retractionnoteasantalolinhibitstheangiogenesisandgrowthofhumanprostatetumorgrowthbytargetingvascularendothelialgrowthfactorreceptor2mediatedaktmtorp70s6ksignalingpathway
AT alhaiderabdulqadera retractionnoteasantalolinhibitstheangiogenesisandgrowthofhumanprostatetumorgrowthbytargetingvascularendothelialgrowthfactorreceptor2mediatedaktmtorp70s6ksignalingpathway